Viewing Study NCT02723994


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-04-18 @ 7:17 AM
Study NCT ID: NCT02723994
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-17
First Post: 2016-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Sponsor: Incyte Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module